Erlotinib-induced interstitial lung disease: characteristics, mechanisms, preventions, and treatment

LEI Zhao-bao

PDF(601 KB)
PDF(601 KB)
Adverse Drug Reactions Journal ›› 2013, Vol. 15 ›› Issue (4) : 211-4. DOI: 10.3760/cma.j.issn.1008-5734.2013.04.009

Erlotinib-induced interstitial lung disease: characteristics, mechanisms, preventions, and treatment

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2013, 15(4): 211-4 https://doi.org/10.3760/cma.j.issn.1008-5734.2013.04.009

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(601 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉